Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Academy for Sickle Cell and Thalassaemia (ASCAT 2026) 7 - 10 October 2026

Etavopivat reduces transfusion in adults and adolescents with transfusion-dependent α- or β-thalassaemia: Phase 2 results

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Thalassemia

Congress oral presentation

Etavopivat